Pharma Foods International Co (2929.T) Stock Price

Pharma Foods International Co Price

🇯🇵JPX·CLOSED
632.00JPY
Market closed
Today +/-
Today %

Pharma Foods International Co (2929.T) Stock | ISIN JP3802310007. The current Pharma Foods International Co stock price is 632 JPY (2026). Market capitalization is 18.38 B JPY. Pharma Foods International Co operates in the Health sector.

Pharma Foods International Co stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Pharma Foods International Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pharma Foods International Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pharma Foods International Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Pharma Foods International Co Stock Price History
DatePharma Foods International Co Price
Access this data via the Eulerpool API

Pharma Foods International Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
1.2 B JPY
173 M JPY
106 M JPY
Jan 1, 2007
1.11 B JPY
-162 M JPY
-130 M JPY
Jan 1, 2008
811 M JPY
-452 M JPY
-455 M JPY
Jan 1, 2009
734 M JPY
-265 M JPY
-208 M JPY
Jan 1, 2010
959 M JPY
-64 M JPY
15 M JPY
Jan 1, 2011
1.01 B JPY
-44 M JPY
-47 M JPY
Jan 1, 2012
1.23 B JPY
71 M JPY
60 M JPY
Jan 1, 2013
1.53 B JPY
217 M JPY
269 M JPY
Jan 1, 2014
1.62 B JPY
-28 M JPY
9 M JPY
Jan 1, 2015
2.17 B JPY
-371.85 M JPY
-187.89 M JPY
Jan 1, 2016
3.46 B JPY
-46.35 M JPY
25.9 M JPY
Jan 1, 2017
4.72 B JPY
89.44 M JPY
101.31 M JPY
Jan 1, 2018
7.94 B JPY
296.43 M JPY
313.66 M JPY
Jan 1, 2019
10.53 B JPY
576.25 M JPY
499.85 M JPY
Jan 1, 2020
15.35 B JPY
740.02 M JPY
690.95 M JPY

Pharma Foods International Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 12:39 PM
 
REVENUE (M JPY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M JPY)
NET INCOME (M JPY)
NET INCOME GROWTH (%)
DIV. (JPY)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Pharma Foods International Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pharma Foods International Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pharma Foods International Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Pharma Foods International Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pharma Foods International Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Pharma Foods International Co stock margins

The Pharma Foods International Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pharma Foods International Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pharma Foods International Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
57.92 %
14.42 %
8.83 %
Jan 1, 2007
59.21 %
-14.62 %
-11.73 %
Jan 1, 2008
34.03 %
-55.73 %
-56.1 %
Jan 1, 2009
33.38 %
-36.1 %
-28.34 %
Jan 1, 2010
46.19 %
-6.67 %
1.56 %
Jan 1, 2011
41.41 %
-4.37 %
-4.67 %
Jan 1, 2012
46.29 %
5.8 %
4.9 %
Jan 1, 2013
58.62 %
14.23 %
17.64 %
Jan 1, 2014
55.85 %
-1.73 %
0.56 %
Jan 1, 2015
63.64 %
-17.17 %
-8.68 %
Jan 1, 2016
71.05 %
-1.34 %
0.75 %
Jan 1, 2017
78.69 %
1.89 %
2.15 %
Jan 1, 2018
79.96 %
3.73 %
3.95 %
Jan 1, 2019
81.05 %
5.47 %
4.75 %
Jan 1, 2020
79.3 %
4.82 %
4.5 %

Pharma Foods International Co Stock Revenue, EBIT, Earnings per Share

The Pharma Foods International Co earnings per share therefore indicates how much revenue Pharma Foods International Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
60 JPY
8.65 JPY
5.3 JPY
Jan 1, 2007
48.17 JPY
-7.04 JPY
-5.65 JPY
Jan 1, 2008
33.79 JPY
-18.83 JPY
-18.96 JPY
Jan 1, 2009
30.58 JPY
-11.04 JPY
-8.67 JPY
Jan 1, 2010
39.96 JPY
-2.67 JPY
0.63 JPY
Jan 1, 2011
41.96 JPY
-1.83 JPY
-1.96 JPY
Jan 1, 2012
51.04 JPY
2.96 JPY
2.5 JPY
Jan 1, 2013
63.54 JPY
9.04 JPY
11.21 JPY
Jan 1, 2014
62.12 JPY
-1.08 JPY
0.35 JPY
Jan 1, 2015
74.76 JPY
-12.84 JPY
-6.49 JPY
Jan 1, 2016
119.2 JPY
-1.6 JPY
0.89 JPY
Jan 1, 2017
162.66 JPY
3.08 JPY
3.49 JPY
Jan 1, 2018
273.53 JPY
10.21 JPY
10.8 JPY
Jan 1, 2019
362.75 JPY
19.85 JPY
17.21 JPY
Jan 1, 2020
528.43 JPY
25.47 JPY
23.78 JPY

Pharma Foods International Co business model & stock analysis

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 670 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Pharma Foods International Co Eulerpool Fair Value

Pharma Foods International Co historical P/E ratio, EBIT multiple, and P/S ratio

Pharma Foods International Co annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Pharma Foods International Co shares outstanding

The number of shares was Pharma Foods International Co in 2025 — This indicates how many shares 28.743 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
20 M base_Shares
Jan 1, 2007
23 M base_Shares
Jan 1, 2008
24 M base_Shares
Jan 1, 2009
24 M base_Shares
Jan 1, 2010
24 M base_Shares
Jan 1, 2011
24 M base_Shares
Jan 1, 2012
24 M base_Shares
Jan 1, 2013
24 M base_Shares
Jan 1, 2014
26 M base_Shares
Jan 1, 2015
28.97 M base_Shares
Jan 1, 2016
29.03 M base_Shares
Jan 1, 2017
29.03 M base_Shares
Jan 1, 2018
29.04 M base_Shares
Jan 1, 2019
29.04 M base_Shares
Jan 1, 2020
29.05 M base_Shares

Pharma Foods International Co Dividend History

7 years of dividend payments

YearAnnual DividendYoY ChangePayments
202612.5JPYYTD
Jan 29, 202612.5JPY 0.0%1/1
202525JPY 0.0%
Jan 30, 202512.5JPY 16.7%1/2
Jul 30, 202512.5JPY 0.0%2/2
202425JPY 13.6%
202322JPY 10.0%
202220JPY 0.0%
202120JPY 135.3%
20208.5JPY

Pharma Foods International Co dividend history and estimates

In 2025, Pharma Foods International Co paid a dividend amounting to 25 JPY. Dividend means that Pharma Foods International Co distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Invalid Date
8.5 JPY
-1.5 JPY
0 JPY
Jan 1, 2021
20 JPY
0 JPY
0 JPY
Jan 1, 2022
20 JPY
0 JPY
0 JPY
Jan 1, 2023
22 JPY
0 JPY
0 JPY
Jan 1, 2024
25 JPY
0 JPY
0 JPY
Jan 1, 2025
25 JPY
0 JPY
0 JPY

Pharma Foods International Co dividend payout ratio

In 2025, Pharma Foods International Co had a payout ratio of 22%. The payout ratio indicates the percentage of the company's profits that Pharma Foods International Co distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2006
25.44 %
Jan 1, 2007
25.44 %
Jan 1, 2008
25.44 %
Jan 1, 2009
25.44 %
Jan 1, 2010
25.44 %
Jan 1, 2011
25.44 %
Jan 1, 2012
25.44 %
Jan 1, 2013
25.44 %
Jan 1, 2014
25.44 %
Jan 1, 2015
25.44 %
Jan 1, 2016
25.44 %
Jan 1, 2017
25.44 %
Jan 1, 2018
25.44 %
Jan 1, 2019
25.44 %
Jan 1, 2020
35.74 %
Price targets and forecasts for Pharma Foods International Co are not yet available.

Pharma Foods International Co shareholder structure

% Name
7.7765%
Kimu (Mujo)
Kimu (Mujo)
5.08941%
PF Holdings Co., Ltd.
PF Holdings Co., Ltd.
4.99312%
Itochu Corp
Itochu Corp
2.85454%
Nomura Asset Management Co., Ltd.
Nomura Asset Management Co., Ltd.
2.64623%
Masuda (Kazuyuki)
Masuda (Kazuyuki)
2.49261%
Kim (Eiichi)
Kim (Eiichi)
2.06327%
Rohto Pharmaceutical Co Ltd
Rohto Pharmaceutical Co Ltd
1.75069%
Kin (Chihiro)
Kin (Chihiro)
1.5588%
Masuda (Mirei)
Masuda (Mirei)
1.55866%
The Vanguard Group, Inc.
The Vanguard Group, Inc.

Pharma Foods International Co Executives and Management Board

MK

Mr. Mujo Kim

(77)

President, Chief Executive Officer, Representative Director · since 1999

KM

Mr. Kazuyuki Masuda

(48)

Senior Managing Director, President of Subsidiaries · since 2008

HH

Mr. Hirotaka Higashiyama

(49)

Director of Biomedical Unit, Director · since 2023

YK

Mr. Yongiru Kim

(43)

Director

YH

Ms. Yukako Hayashi

(62)

Independent Director

Pharma Foods International Co Supply Chain

Frequently asked questions about Pharma Foods International Co

All fundamentals and in-depth analysis of Pharma Foods International Co

Our stock analysis for Pharma Foods International Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma Foods International Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.